Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortHospital antibiotic for MRSA and C. difficile.Reserve antibiotic for MRSA, VRE and resistant TB.
Body systemAntibioticsAntibiotics
Drug classGlycopeptidesOxazolidinones
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesMRSA infections, Sepsis with resistant bacteria, Endocarditis, C. difficile colitis (oral), Meningitis (with other drugs)MRSA pneumonia and skin infections, Vancomycin-resistant enterococcus (VRE), Drug-resistant tuberculosis (BPaLM regimen)
How it worksGrabs the building blocks of the bacterial wall so they can't link up.Stops bacterial ribosomes forming at all.
Starts working——
Half-life4–6 hours (longer in kidney disease)5–7 hours
Typical adult doseIV: weight-based, adjusted to blood levels. C. difficile: 125 mg by mouth four times a day for 10 days.600 mg twice a day (once a day in TB regimens).
FormsIV infusion, Capsule, Oral solutionTablet, Oral suspension, IV infusion
Common side effectsFlushing and itching if infused too fast, Rash, NauseaDiarrhoea, Headache, Nausea, Taste change
Serious side effectsKidney injury, Hearing damage, Low white cellsLow platelets and anaemia (over 2 weeks), Optic and peripheral nerve damage, Serotonin syndrome, Lactic acidosis
Don't take if——
Alcohol——
PregnancyUse with cautionUsed when needed; levels monitored.Use with cautionLimited data.
Breastfeeding——
In use since19582000
Brand namesUnited States: Vancocin, FirvanqUnited Kingdom: VancocinUnited States: ZyvoxUnited Kingdom: ZyvoxIndia: Linospan, Lizolid
Legal status——
ATC codeJ01XA01J01XX08

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker